Journals / Türkiye Diyabet ve Obezite Dergisi / 2022 / Cilt: 6 - Sayı: 2

The Effect of Dexamethasone Implant on Retinal Nerve Fiber Layer and Optic Nerve Cup-to-Disk Ratio in Patients with Diabetic Macular Edema

Diyabetik Makula Ödemli Hastalarda Deksametazon İmplantının Retina Sinir Lifi Tabakası ve Optik Sinir Çukurluk/Disk Oranı Üzerine Etkisi

Pages
143–148
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This reduction did not cause a significant morphological change in the C/D value.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study is to investigate the effect of single-dose intravitreal Dexamethasone (DEX) implant on peripapillary retinal nerve fiber layer (RNFL) thickness and cup-to-disc (C/D) ratio in patients with diabetic macular edema.
📊
Key Findings & Data:Material and Methods: Peripapillary RNFL thickness measurements and colored fundus photographs were compared before and 6 months after intravitreal DEX implant injection.
💡
Conclusion & Impact:This reduction did not cause a significant morphological change in the C/D value.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Deksametazon implant · Diyabetik maküler ödem · İntravitreal enjeksiyon

Abstract

Aim: The aim of this study is to investigate the effect of single-dose intravitreal Dexamethasone (DEX) implant on peripapillary retinal nerve fiber layer (RNFL) thickness and cup-to-disc (C/D) ratio in patients with diabetic macular edema. Material and Methods: Peripapillary RNFL thickness measurements and colored fundus photographs were compared before and 6 months after intravitreal DEX implant injection. The cup-to-disc ratios of fundus photographs were calculated using the Image-J program. Results: Fifty-eight eyes of 43 patients were treated with intravitreal DEX implants. The mean global and sectoral peripapillary RNFL thickness value had a slight thinning over the basal value. The global and nasal thinning was statistically significant (respectively; p=0.021, p=0.036). A small increase in C/D value was observed 6 months after the DEX implant injection; however, these changes were not statistically significant (p=0.285). The intraocular pressure was over 25 mmHg in 17% of the patients and it was controlled by medical treatment. Conclusion: In this study, in patients with diabetic macular edema, a mild but significant thinning of the global and nasal peripapillary retinal nerve fiber layer was observed 6 months after single-dose intravitreal implant treatment. This reduction did not cause a significant morphological change in the C/D value.

Özet

Amaç: Bu çalışmanın amacı diyabetik maküla ödemi bulunan hastalarda tek doz intravitreal Deksametazon (DEX) implantının peripapiller retina sinir lifi tabakası (RNFL) kalınlığına ve optik sinir çukurluk/disk (C/D) oranına etkisini araştırmaktır. Gereç ve Yöntemler: İntravitreal DEX implant enjeksiyonu öncesi peripapiller RNFL kalınlık ölçümleri ve renkli fundus fotoğrafları enjeksiyondan 6 ay sonrası ile karşılaştırıldı. Fundus fotoğraflarının C/D oranları Image-J programı kullanılarak hesaplandı. Bulgular: Kırk üç hastanın 58 gözüne intravitreal DEX implant enjeksiyonu yapıldı. Ortalama global ve sektörel RNFL kalınlık değerleri bazal değere göre hafif bir incelme gösterdi. Global ve nazal incelme istatistiksel olarak anlamlıydı (sırasıyla; p=0,021, p=0,036). DEX implant enjeksiyonundan 6 ay sonra C/D değerinde hafif bir artış gözlendi, ancak bu artış istatistiksel olarak anlamlı değildi (p=0,258). Hastaların %17’sinde göz içi basıncı 25 mmHg’nin üzerindeydi ve medikal tedavi ile kontrol altına alındı. Sonuç: Bu çalışmada diyabetik maküla ödemi olan hastalarda tek doz intravitreal DEX tedavisinden 6 ay sonra global ve nazal peripapiller retina sinir lifi tabakasında hafif fakat belirgin bir incelme gözlemlendi. Bu azalma, C/D değerinde önemli bir morfolojik değişikliğe neden olmadı.

🔖

Cite This Article

KÜÇÜK, N., ALPAY, A. (2022). The Effect of Dexamethasone Implant on Retinal Nerve Fiber Layer and Optic Nerve Cup-to-Disk Ratio in Patients with Diabetic Macular Edema. Türkiye Diyabet ve Obezite Dergisi, Cilt: 6 - Sayı: 2, 143–148. https://ajindex.com/articles/627252

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009; 116: 497-503
  2. Ehrlich R, Harris A, Ciulla TA, et al. Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process. Acta Ophthalmol 2010; 88: 279-291
  3. Erickson KK, Sundstrom JM, Antonetti DA. Vascular permeability in ocular disease and the role of tight junctions. Angiogenesis 2007; 10: 103-117
  4. Tamura H, Miyamoto K, Kiryu J, et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Investigative Ophthalmology & Visual Science 2005; 46: 1440-1444
  5. Chang-Lin JE, Attar M, Acheampong AA, et al. Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant. Investigative Ophthalmology & Visual Science 2011; 52: 80-86
  6. Sarao V, Veritti D, Boscia F, Lanzetta P. Intravitreal Steroids for the Treatment of Retinal Diseases. Scientific World Journal 2014
  7. Boyer DS, Yoon YH, Belfort R, et al. Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema. Ophthalmology 2014; 121: 1904-1914
  8. Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 2008; 88: 1322-1335
  9. Lam WC, Albiani DA, Yoganathan P, et al. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study. Clin Ophthalmol 2015; 9: 1255-1268
  10. Mazzarella S, Mateo C, Freixes S, et al. Effect of intravitreal injection of dexamethasone 0.7 mg (Ozurdex(R)) on intraocular pressure in patients with macular edema. Ophthalmic Res 2015; 54: 143-149
  11. Maturi RK, Pollack A, Uy HS, et al. Intraocular Pressure in Patients with Diabetic Macular Edema Treated with Dexamethasone Intravitreal Implant in the 3-Year Mead Study. Retina-the Journal of Retinal and Vitreous Diseases 2016; 36: 1143-1152
  12. Abraham IM, Meerlo P, Luiten PG. Concentration dependent actions of glucocorticoids on neuronal viability and survival. Dose Response 2006; 4: 38-54
  13. Siqueira RC, Dos Santos WF, Scott IU, et al. Neuroprotective effects of intravitreal triamcinolone acetonide and dexamethasone implant in rabbit retinas after pars plana vitrectomy and silicone oil injection. Retina 2015; 35: 36